Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03601741
Other study ID # 17-01633
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 8, 2018
Est. completion date April 5, 2019

Study information

Verified date September 2019
Source NYU Langone Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective pilot study using a randomized, controlled, single blinded, crossover trial design, evaluating the effect of daily antimicrobial stethoscope diaphragm covers versus uncovered stethoscope. Stethoscopes will be cleaned Sani-cloth germicidal disposable wipes which are effective against MRSA. Each participant will then be randomly assigned to 7 days in either the intervention or the control arm. At the end of the 7 days participants stethoscopes will be cleaned again. This will be followed by another 7 days in the arm that they are not in during the first 7 days.

The primary endpoint is MRSA colony count from stethoscope diaphragms cultures at 7 days, focusing on the difference between the intervention and the control periods. The secondary endpoint is the rate of hospital acquired MRSA infection in patients treated by residents during each period.


Recruitment information / eligibility

Status Completed
Enrollment 1
Est. completion date April 5, 2019
Est. primary completion date April 5, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Internal Medicine Residents

Exclusion Criteria:

- NA

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Daily Antimicrobial Stethoscope Diaphragm Cover
Patients will receive package with instructions to use stethoscope cover, and are then instructed to switch in 7 days
Uncovered Stethoscopes
Patients receive instruction to begin with no covers, and are then instructed to switch in 7 days

Locations

Country Name City State
United States New York University School of Medicine New York New York

Sponsors (1)

Lead Sponsor Collaborator
NYU Langone Health

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary MRSA colony count cultured from stethoscope diaphragms Total CFU of each selected pathogen at 7 days compared by paired Mann-Whitney U tests, with each patient serving as their own control 7 Days
Secondary Rate of hospital acquired MRSA infection in patients treated by participating residents Rates on nosocomial infection in each arm compared through use of Kaplan Meier curves 14 Days
See also
  Status Clinical Trial Phase
Completed NCT03181932 - AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis Phase 3
Completed NCT03268122 - Comparison of Standard Isolation With Targeted Isolation for Preventing Nosocomial Transmission of MRSA and VRE N/A
Completed NCT04312776 - Tracing MRSA in Households With Patients Infected With CA-MRSA by WGS
Recruiting NCT04104178 - Optimal Treatment of MRSA Throat Carriers Phase 3
Recruiting NCT04793152 - Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC N/A
Completed NCT02690415 - Community-Assoc. S. Aureus Colonization and Recurrent Infection in Pts With Uncomplicated S. Aureus Skin Abscesses
Enrolling by invitation NCT04297592 - Antibiotic Prophylaxis in High-Risk Arthroplasty Patients Phase 4
Recruiting NCT05268120 - MRSA Decolonization in Complicated Carriage N/A
Completed NCT01167452 - Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations Phase 4
Recruiting NCT04083092 - Surveillance of Community-Associated MRSA
Recruiting NCT02443064 - Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin Phase 4
Completed NCT02029872 - Stop Community MRSA Colonization Among Patients Phase 4
Not yet recruiting NCT05696132 - Evaluation of the Decolonization Rate and Acceptance of a Complete Nasal Decolonization Kit With Povidone Iodine for MRSA Patients Phase 2
Recruiting NCT02127658 - MRSA Eradication and Decolonization in Children N/A
Completed NCT00822276 - The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA) N/A
Withdrawn NCT02547116 - Epidemiology and Treatment of Small-colony Variant Staphylococcus Aureus in Cystic Fibrosis Phase 4
Completed NCT01318213 - Benefits of Universal Glove and Gowning
Completed NCT03304873 - Retapamulin as a Decolonizing Agent for MRSA Phase 3
Enrolling by invitation NCT05395520 - Vancomycin Monitoring: Is AUC Monitoring Appropriate for More Than Just Serious MRSA Infections?